Growth Metrics

TELA Bio (TELA) Raw Materials (2023 - 2025)

TELA Bio's quarterly Raw Materials came in at $118000.0 in Q4 2025, down 13.24% year-on-year from $136000.0 in Q4 2024, and down 13.24% quarter-over-quarter from $136000.0 in Q4 2024.

TELA Bio has reported Raw Materials for 3 years, with the latest figure at $118000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials fell 13.24% year-over-year to $118000.0; the trailing twelve-month figure through Dec 2025 stood at $118000.0 (down 13.24% YoY), and the FY2025 full-year result was $118000.0, down 13.24% from the prior year.
  • Raw Materials for Q4 2025 stood at $118000.0, down from $136000.0 in the prior quarter.
  • The five-year high for Raw Materials was $136000.0 in Q4 2024, with the low at $60000.0 in Q4 2023.
  • Average Raw Materials over 3 years is $104666.7, with a median of $118000.0 recorded in 2025.
  • Year-over-year, Raw Materials jumped 126.67% in 2024 and decreased 13.24% in 2025.
  • Tracing TELA's Raw Materials over 3 years: stood at $60000.0 in 2023, then jumped by 126.67% to $136000.0 in 2024, then retreated by 13.24% to $118000.0 in 2025.
  • The last three Raw Materials figures came in at $118000.0 (Q4 2025), $136000.0 (Q4 2024), and $60000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 TELA Bio 13.26 Mn -26.28 Mn 12.52 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 118,000.00
Dec 31, 2024 136,000.00
Dec 31, 2023 60,000.00